Skip to content

Multimodal prehabilitation reduces postoperative complications in highrisk patients undergoing major gastrointestinal cancer surgery – a multicentre, randomised, controlled trial

Multimodal prehabilitation reduces postoperative complications in highrisk patients undergoing major gastrointestinal cancer surgery – a multicentre, randomised, controlled trial - PREHAB Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00037031
Enrollment
401
Registered
2026-01-13
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prehabilitation before oncological surgery

Interventions

Group 1: The intervention group will receive a supervised progressive exercise programme conducted and supervised by a professional sport therapist, consisting of three 50-min sessions per week. Each

Sponsors

Uniklinik Köln
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Candidate to elective major gastrointestinal cancer surgery (pelvic exenteration, cytoreductive surgery, oesophagectomy, hepatectomy, pancreatectomy, rectum resection); 2) High risk for surgical complications defined by presence of comorbid disease such as deconditioning, heart disease, diabetes, renal impairment or morbid obesity; 3) Duke Activity Status Index score (DASI) <402; 5) Schedule allowing for at least 4 weeks for intervention with multimodal prehabilitation prior to surgery / willingness to exercise

Exclusion criteria

Exclusion criteria: 1) Non-elective surgery; 2) Unstable cardiac or respiratory disease; 3) Locomotor limitations precluding exercise training; 4) Cognitive deterioration impeding adherence to the programme; 5) Enrolment in other research studies affecting study endpoint

Design outcomes

Primary

MeasureTime frame
The primary endpoint of the study is postoperative complications (Clavien-Dindo Classification grade III-V). Observation period will be 90 days. Clavien-Dindo Classification is a well-known, metric and validated outcome parameter that is sensitive to surgical risk and prognostic association to long-term (five-year) survival in cancer patients. We will analyse this outcome in the context of clinically relevant time window (30days after surgery or time of patient’s discharge), where, based on our preliminary data, most of the CDIII-V complications occur. Preliminary prehabilitation studies have shown that it is feasible to exercise patients preoperatively and improve functional capacity. Yet to date, there are no adequately powered multicentre, randomised, controlled trials investigating on the efficacy of prehabilitation on postoperative complications.

Secondary

MeasureTime frame
Secondary outcomes include postoperative Comprehensive Complication Index (CCI), medical complications (i.e. cardiac, pulmonary, sepsis => all complications will be predefined in protocol), length of ICU stay (LOICUS), Hospital Length of Stay (HLOS), Days at home after surgery (DAH-30), cost-effectiveness / -utility analysis (RAND, iPCQ/iMCQ), functional capacity (CPET, DASI) and quality of life (HRQoL, EORTC QLQ-C30).

Countries

Germany

Contacts

Public ContactRobert Schier

Uniklinik Köln

anaesthesiologie@uk-koeln.de+49 221 478 82054

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026